This inventor holds 22 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Antibody Therapeutics. Top assignees: Sorrento Therapeutics, Inc., Scripps Research Institute, Vivasor, Inc.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
20 out of 114 
1 out of 1,208 
1 out of 11 Years Active: 2014-2024
Areas of Expertise:
Title: **Innovative Contributions of Gunnar F Kaufmann**
Introduction
Gunnar F Kaufmann, based in San Diego, CA, has established himself as a prominent inventor with a remarkable portfolio that includes 22 patents. His work primarily focuses on advancements in the field of biotechnology, particularly in the development of innovative antigen receptors and binding proteins.
Latest Patents
Among his latest contributions are two significant patents. The first patent outlines dimeric antigen receptors (DAR) constructs that feature a heavy chain binding region on one polypeptide chain and a light chain binding region on another. These dimeric antigen receptors can dimerize, thereby forming an antigen binding domain with antibody-like properties, allowing for specific binding to target antigens. This innovation has promising implications for directed cell therapy.
The second patent revolves around antigen binding proteins that target PD-L1, detailing compositions and methods derived from anti-PD-L1 antibodies. This patent discloses fully human antibodies that bind PD-L1, along with fragments, derivatives, and nucleic acids encoding these antibodies. Furthermore, it explores methods of utilizing these antibodies for treating or diagnosing PD-L1 related disorders, including various inflammatory conditions and cancers.
Career Highlights
Throughout his career, Gunnar F Kaufmann has been associated with several esteemed organizations. Notably, he has worked at Sorrento Therapeutics, Inc. and The Scripps Research Institute, where he has contributed to significant research and development efforts in the field of biotechnology.
Collaborations
Kaufmann's journey is marked by fruitful collaborations with notable colleagues, including Heyue Zhou and Barbara Anne Swanson, which have likely enhanced his innovative approach and broadened the scope of his inventions.
Conclusion
Gunnar F Kaufmann's contributions to the field of biotechnology through his patents and collaborations illustrate his commitment to innovation. His work continues to pave the way for advancements in targeted therapies, showcasing the vital role of inventors in transforming scientific discoveries into real-world applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile